VINC
Vincerx Pharma, Inc. Common Stock
VINC
VINC
Delisted
VINC was delisted on the 22nd of April, 2025.
32 hedge funds and large institutions have $11.7M invested in Vincerx Pharma, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
32
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$41.5K | |
| 2 | +$36.2K | |
| 3 | +$24K | |
| 4 |
Morgan Stanley
New York
|
+$8.99K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$17 |
Top Sellers
| 1 | -$311K | |
| 2 | -$297K | |
| 3 | -$99.9K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$57.9K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$55K |